Monday, February 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ingredion Collaborates with Better Juice to Provide Innovative Sugar Reduction Solutions

Elaine Mendonca by Elaine Mendonca
January 17, 2024
in Breaking News
0
Food Producers Trading online
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On January 17, 2024, Ingredion made an exciting collaboration with Better Juice to provide innovative sugar reduction solutions. Better Juice has developed groundbreaking technology that effectively eliminates simple sugars from juice-based beverages, concentrates, and other natural sugar products. This partnership will allow Ingredion to introduce Better Juice’s sugar reduction technology to its extensive customer base starting in the second quarter of 2024.

Ingredion is renowned for its comprehensive range of category-specific sugar reduction solutions. These include functional rare sugars, syrups, and naturally derived stevia sweeteners. These offerings enable the creation of delicious reduced-sugar products without compromising on taste or personalized nutrition requirements. Ingredion is committed to sharing its extensive expertise in sugar reduction and its wide ingredient portfolio to assist customers in finding the perfect ingredients for their sugar reduction and functional build-back needs.

Ingredion Incorporated (INGR) Showcases Strong Stock Performance with Potential for Rebound

On January 17, 2024, Ingredion Incorporated (INGR) showcased promising stock performances. The company’s stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum.

Despite the overall positive trend, INGR experienced a slight decline in its stock price since the market last closed. The price of INGR shares dropped by $0.34, representing a 0.31% decrease. The stock closed at $109.52, reflecting a minor setback.

However, it is worth noting that INGR’s stock remained unchanged in after-hours trading, suggesting stability and potential for a rebound in the future.

Ingredion Incorporated is a leading global ingredient solutions provider. The company offers a wide range of products and services to various industries, including food, beverage, brewing, pharmaceuticals, and more.

The fact that INGR is trading near the top of its 52-week range is a positive sign for investors. It suggests that the stock has been performing well over the past year and has the potential for further growth. Additionally, being above its 200-day simple moving average indicates a sustained upward trend, further bolstering investor confidence.

While the slight drop in INGR’s stock price may be disheartening for some investors, it is important to consider the bigger picture. The stock’s stability in after-hours trading suggests that this decline may be temporary and not indicative of a significant downturn. Investors should monitor the stock closely in the coming days to see if it rebounds and continues its positive momentum.

Overall, INGR’s stock performances on January 17, 2024, highlight the company’s strong position in the market. Trading near the top of its 52-week range and above its 200-day simple moving average signifies positive price momentum. While the slight drop in stock price may cause concern, the stock’s stability in after-hours trading indicates the potential for a rebound. Investors should keep a close eye on INGR’s future performances to make informed decisions regarding their investments.

Ingredion Incorporated (INGR) Shows Stable Performance and Positive Growth in Stock Market

On January 17, 2024, Ingredion Incorporated (INGR) showcased a stable performance in the stock market. The company’s financials indicate positive growth and consistent earnings. Total revenue for Ingredion Incorporated in the past year stood at $7.95 billion, representing a 15.26% increase compared to the previous year. Net income for INGR during the past year reached $492 million, reflecting a remarkable 320.51% increase compared to the previous year. Earnings per share (EPS) for Ingredion Incorporated stood at $7.34 for the past year, exhibiting a substantial increase of 325.53% compared to the previous year. Overall, Ingredion Incorporated’s stock performance on January 17, 2024, remained steady. The company showcased a positive growth in total revenue, net income, and earnings per share over the past year. Investors may interpret this performance as a sign of stability and consistent earnings for Ingredion Incorporated. The company’s ability to increase net income by over 320% in the past year demonstrates its strong financial management and potential for future growth. However, the slight decline in net income and the lack of significant growth in the third quarter may warrant further analysis to understand the factors behind these trends. It is essential to consider other factors such as market conditions, industry trends, and competitive landscape before making any investment decisions. Conducting thorough research and consulting with financial advisors is crucial to make informed investment choices.

Tags: INGR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics stock Trading (1)

Perion Network Ltd Partners with Amazon Publisher Services to Revolutionize Video Monetization

Biotechnology Stock Bull Market

Transcode Therapeutics Inc Follows Biopharmaceutical Trend with Public Offering of Common Stock

Finance_ stocks to buy

Understanding the Importance of Resumption Quote Time for Trading Halts

Recommended

Marsh McLennan Stock

Market Experts Remain Cautious on Marsh McLennan Despite Strong Earnings

5 months ago
JPMorgan Stock

Leadership Shift at JPMorgan as Shares Approach Record High

4 months ago
Solana Stock

Solana at a Crossroads: Institutional Accumulation Meets Retail Fear

2 months ago
D-Wave Quantum Stock

D-Wave Quantum Warrants Face Expiration Deadline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

FTI Consulting’s Strategic Mandate and Upcoming Financial Report

Figma’s AI Pivot Faces Crucial Earnings Test

Super Micro Computer’s Earnings Report: A Crucial Test for Investor Confidence

Apex Critical Metals Commences Drilling at Key U.S. Rare Earths Project

Chevron Boosts Shareholder Returns and Eyes Production Growth

Investors Await Coca-Cola’s Earnings Report Amid Leadership Transition

Trending

UiPath Registered (A) Stock
AI & Quantum Computing

UiPath Charts a Course in Autonomous AI for Enterprise Growth

by Dieter Jaworski
February 2, 2026
0

The enterprise automation specialist UiPath is sharpening its strategic emphasis on what it terms "Agentic AI," a...

Ethereum Stock

Regulatory Gridlock Weighs on Ethereum’s Early 2026 Performance

February 2, 2026
Colgate-Palmolive Stock

Analysts Boost Targets as Colgate-Palmolive Posts Strong Quarterly Performance

February 2, 2026
FTI Consulting Stock

FTI Consulting’s Strategic Mandate and Upcoming Financial Report

February 2, 2026
Figma Stock

Figma’s AI Pivot Faces Crucial Earnings Test

February 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UiPath Charts a Course in Autonomous AI for Enterprise Growth
  • Regulatory Gridlock Weighs on Ethereum’s Early 2026 Performance
  • Analysts Boost Targets as Colgate-Palmolive Posts Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com